ABT vs. CI: A Head-to-Head Stock Comparison
UpdatedHere’s a clear look at ABT and CI, comparing key factors like performance, valuation metrics, dividends, and financial strength. It’s built for investors or anyone curious to see how these two stocks match up.
Company Overview
ABT dominates in value with a market cap of 231.49 billion USD, eclipsing CI’s 84.71 billion USD by roughly 2.73×.
ABT’s beta of 0.74 points to much larger expected swings compared to CI’s calmer 0.48, suggesting both higher upside and downside potential.
| Symbol | ABT | CI |
|---|---|---|
| Company Name | Abbott Laboratories | Cigna Corporation |
| Country | US | US |
| Sector | Healthcare | Healthcare |
| Industry | Medical - Devices | Medical - Healthcare Plans |
| CEO | Mr. Robert B. Ford | Mr. David Michael Cordani |
| Price | 133.05 USD | 317.09 USD |
| Market Cap | 231.49 billion USD | 84.71 billion USD |
| Beta | 0.74 | 0.48 |
| Exchange | NYSE | NYSE |
| IPO Date | March 17, 1980 | March 31, 1982 |
| ADR | No | No |
Performance Comparison
This chart compares the performance of ABT and CI over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).
Hover over the lines to see the investment’s value and total return (%) at specific dates.
Data is adjusted for dividends and splits.
Valuation Metrics Comparison
For a detailed comparison of valuation metrics between ABT and CI, please refer to the table below.
| Symbol | ABT | CI |
|---|---|---|
| Price-to-Earnings Ratio (P/E, TTM) | 17.22 | 17.66 |
| Forward PEG Ratio (TTM) | 1.73 | 1.52 |
| Price-to-Sales Ratio (P/S, TTM) | 5.47 | 0.33 |
| Price-to-Book Ratio (P/B, TTM) | 2.48 | 2.21 |
| Price-to-Free Cash Flow Ratio (P/FCF, TTM) | 34.77 | 14.09 |
| EV-to-EBITDA (TTM) | 22.97 | 9.69 |
| EV-to-Sales (TTM) | 5.63 | 0.42 |
| EV-to-Free Cash Flow (TTM) | 35.78 | 17.77 |
Dividend Comparison
Both ABT and CI offer similar dividend yields (1.71% vs. 1.80%), indicating comparable approaches to balancing income and growth.
| Symbol | ABT | CI |
|---|---|---|
| Dividend Yield (TTM) | 1.71% | 1.80% |
Financial Strength Metrics Comparison
This section dives into the financial resilience of ABT and CI, spotlighting key metrics like liquidity, leverage, and debt coverage. Check out the standout observations below where notable differences or extremes pop up.
- CI’s current ratio of 0.78 indicates its assets may not cover near-term debts, whereas ABT at 1.78 maintains healthy liquidity.
- CI posts a quick ratio of 0.69, indicating limited coverage of short-term debts from its most liquid assets—while ABT at 1.27 enjoys stronger liquidity resilience.
| Symbol | ABT | CI |
|---|---|---|
| Current Ratio (TTM) | 1.78 | 0.78 |
| Quick Ratio (TTM) | 1.27 | 0.69 |
| Debt-to-Equity Ratio (TTM) | 0.14 | 0.76 |
| Debt-to-Assets Ratio (TTM) | 0.16 | 0.20 |
| Interest Coverage Ratio (TTM) | 15.39 | 4.64 |